OneMedNet Corporation
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ONMD research report →
Price Chart
About the company
OneMedNet Corporation offers advanced solutions for clinical imaging. Their core product, iRWD, is an artificial intelligence-driven platform that securely anonymizes, searches for, and organizes imaging data. This system is utilized by their extensive network of medical and academic research institutions, with the goal of fostering significant progress in medical research, new discoveries, and diagnostic techniques across the broader field of life sciences.
- CEO
- Aaron Green
- IPO
- 2021
- Employees
- 23
- HQ
- Eden Prairie, MN, US
Get TickerSpark's AI analysis on ONMD
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $33.84M
- P/E
- -3.51
- PEG
- 0.01
- P/S
- 23.24
- P/B
- -9.80
- EV/EBITDA
- -4.00
- Div Yield
- 0.00%
- Gross Margin
- -68.82%
- Op Margin
- -695.74%
- Net Margin
- -584.20%
- ROE
- 234.63%
- ROIC
- 362.69%
Latest fiscal year · YoY change
- Revenue
- $1.36M+111.4%
- Gross Profit
- $-503,000-79.0%
- Op Income
- $-9,667,000
- Net Income
- $-2,801,000+72.3%
- EPS
- $-0.06+83.3%
- OCF Growth
- -7.4%
- FCF Growth
- -6.9%
- 52W High
- $4.22
- 52W Low
- $0.49
- 50D MA
- $0.66
- 200D MA
- $0.94
- Beta
- 1.16
- RSI (14)
- 42
- Avg Volume
- 1.09M
No earnings-call transcripts are available for ONMD yet.
- Free Float
- 66.0%
- Shares Outstanding
- 56.95M
- Float Shares
- 37.61M
of shares held by institutions
23 13F filers
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Exencial Wealth Advisors, LLC | 8.38M | ▲ 4.73M |
| Vanguard Group Inc | 1.30M | ▲ 319.07K |
Held by 19 ETFs
Biggest fund positions in ONMD by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jul 30, 26 | Kosasa Thomas | buy | 1,449,275 |
| Jun 23, 26 | Green Aaron | buy | 36,650 |
| Jun 23, 26 | Yu Jeffrey | buy | 158,730 |
| Jun 16, 26 | Yu Jeffrey | buy | 172,414 |
| Jun 15, 26 | Green Aaron | buy | 18,702 |
| Jun 12, 26 | Green Aaron | buy | 36,920 |
| Jun 12, 26 | Kosasa Thomas | buy | 158,730 |
| May 18, 26 | Kosasa Thomas | buy | 268,817 |
| Apr 1, 26 | Yu Jeffrey | other | 219,429 |
| Apr 1, 26 | Yu Jeffrey | buy | 903,614 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our ONMD coverage
Recent articles, reports, and earnings notes.
No research on ONMD yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate ONMD report →OneMedNet (NASDAQ:ONMD) Director Acquires $999,999.75 in Stock
defenseworld.net · Aug 10
OneMedNet Secures $11.5+ Million Agreement to Supply Regulatory-Grade Real-World Data for Foundational AI Model Development
globenewswire.com · Jul 28
OneMedNet Executes on Growth Strategy: Secures Over $3 Million in New Bookings, Surpassing Full-Year 2025
globenewswire.com · Jun 10
OneMedNet Surpasses 90 Million Patient Journeys and 270 Million Studies within its Network
globenewswire.com · Jun 3
Insider Buying: OneMedNet (NASDAQ:ONMD) Director Acquires $249,999.22 in Stock
defenseworld.net · Apr 27
OneMedNet Goes Live with 80 Million Patient Journeys and Billions of Records
globenewswire.com · Apr 22
OneMedNet Announces Strong 2025 Financials and Advances AI-Driven iRWD™ powered by Palantir Foundry enabling Conversational Search on Real-Time Medical Data
globenewswire.com · Apr 6
OneMedNet, Onco-Innovations and Inka Health Announces Collaboration Aimed to Accelerate Potential for Oncology Drug Development Using Real-World Data and AI
globenewswire.com · Apr 1
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.